Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
Status:
Terminated
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above
normal body temperature. Peritoneal infusion of heated chemotherapy drugs, such as mitomycin,
may kill more tumor cells.
PURPOSE: This phase II trial is studying how well mitomycin works when given as a
hyperthermic peritoneal perfusion in treating patients with malignant ascites.